PATRICK NGUYEN: Open Payments
NPI 1063109197 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 14 payments from 9 companies in 2025. Trend: 2023 $462 · 2024 $656 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $369 |
| ABBVIE INC. | 3 | $158 |
| Integra LifeSciences Corporation | 1 | $150 |
| GENZYME CORPORATION | 1 | $125 |
| Novo Nordisk Inc | 1 | $120 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Becton, Dickinson and Company | 1 | $67 |
| Davol Inc. | 2 | $47 |
| Ethicon US, LLC | 1 | $24 |
Products named: OFEV, OMNIGRAFT, CREON, DUPIXENT, Ozempic, NUCALA, Phasix Mesh, ARISTA.
Industry payments across CA — which companies pay providers there.
